Optimizing how cells interact with materials for better signaling
Tuning multivalency for optimized ligand presentation
This study is exploring how cells talk to their surroundings by using special materials that help improve the way they interact with important signals, which could lead to better treatments in medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-10914158 on NIH RePORTER |
What this research studies
This research focuses on understanding how cells communicate with their environment by engaging with multiple ligands on materials. By recreating these interactions using synthetic substrates, the project aims to enhance the way ligands are presented to cells, which is crucial for effective cell signaling. The researchers will develop models to predict how these ligands can be optimized for better performance, utilizing advanced techniques like molecular dynamics simulations and automated synthesis platforms. This work could lead to significant advancements in biomaterials and nanomedicine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions affecting bone health or those requiring advanced biomaterial treatments.
Not a fit: Patients with conditions unrelated to cell signaling or bone formation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve therapies that rely on cell signaling, potentially leading to better treatments for conditions related to bone formation and other cellular interactions.
How similar studies have performed: Similar research has shown promise in enhancing cell-material interactions, indicating that this approach could lead to meaningful advancements.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Gormley, Adam Joseph — Rutgers, the State Univ of N.j.
- Study coordinator: Gormley, Adam Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.